NEON THERAPEUTICS, INC. Stock-Based Compensation
NEON THERAPEUTICS, INC. reported Stock-Based Compensation of $1.67 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2020-05-01
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $1.67M, a 3.47% decline year-over-year.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $1.52M, a 0.59% increase year-over-year.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $2.03M, a 23.80% increase year-over-year.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $2.05M, a 44.44% increase year-over-year.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2019 was $7.34M, a 17.84% increase from fiscal 2018.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2018 was $6.23M, a 104.77% increase from fiscal 2017.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2017 was $3.04M, a 122.04% increase from fiscal 2016.
- NEON THERAPEUTICS, INC. share-based payment arrangement, noncash expense for fiscal 2016 was $1.37M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2020-03-31 | $1.67M 10-Q · filed 2020-05-01 | $3.19M derived: sum of 2 quarters · filed 2020-05-01 | $5.23M derived: sum of 3 quarters · filed 2020-05-01 | $7.28M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.56M derived: sum of 2 quarters · filed 2020-03-02 | $5.61M derived: sum of 3 quarters · filed 2020-03-02 | $7.34M 10-K · filed 2020-03-02 |
| 2019-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $4.09M derived: sum of 2 quarters · filed 2019-11-12 | $5.82M 10-Q · filed 2019-11-12 | $7.33M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.78M 10-Q · filed 2019-08-06 | $5.30M derived: sum of 3 quarters · filed 2020-05-01 | $6.94M derived: sum of 4 quarters · filed 2020-05-01 |
| 2019-03-31 | $1.73M 10-Q · filed 2020-05-01 | $3.24M derived: sum of 2 quarters · filed 2020-05-01 | $4.89M derived: sum of 3 quarters · filed 2020-05-01 | $6.31M derived: sum of 4 quarters · filed 2020-05-01 |
| 2018-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.16M derived: sum of 2 quarters · filed 2020-03-02 | $4.58M derived: sum of 3 quarters · filed 2020-03-02 | $6.23M 10-K · filed 2020-03-02 |
| 2018-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $3.06M derived: sum of 2 quarters · filed 2019-11-12 | $4.71M 10-Q · filed 2019-11-12 | $5.63M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $3.07M 10-Q · filed 2019-08-06 | $3.99M derived: sum of 3 quarters · filed 2019-08-06 | $4.72M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $1.65M 10-Q · filed 2019-05-13 | $2.57M derived: sum of 2 quarters · filed 2019-05-13 | $3.29M derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $916.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $1.65M derived: sum of 2 quarters · filed 2019-03-11 | $3.04M 10-K · filed 2019-03-11 | |
| 2017-09-30 | $729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $2.13M 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $1.40M 10-Q · filed 2018-08-06 | |||
| 2016-12-31 | $1.37M 10-K · filed 2019-03-11 |